Business
The Starpharma (ASX:SPL) share price is 35% below its 52-week high
Shares in mid-cap ASX biopharmaceuticals company Starpharma Holdings Limited (ASX: SPL) have endured a volatile start to 2021. After surging to an all-time high of $2.52 by mid-February, the company’s shares have now plunged more than 35% to just $1.62 as at the time of writing.
While…
Continue Reading
-
Noosa News12 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News17 hours agoGood Charlotte are Touring Australia and New Zealand in 2026
-
Noosa News9 hours agoDavid’s neighbour died alone. He now knows what comes next
-
General11 hours agoACT family violence victims ‘waiting 3 or 4 days’ for help, inquiry hears